Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online

Human Anti-Influenza virus B IgA ELISA Kit (ab108744)

Submit a review Q&A (2)
Serologic ELISA assay principle

    Key features and details

    • Sample type: Cit plasma, Hep Plasma, Serum
    • Detection method: Colorimetric
    • Assay type: Indirect
    • Reacts with: Human

    製品の概要

    • 製品名

      Human Anti-Influenza virus B IgA ELISA Kit

    • 検出方法

      Colorimetric

    • 再現性

      Intra-Assay（同時再現性）
      サンプル N 平均値 SD CV%
      Pos.Serum 7 2.8%
      Inter-Assay（日差再現性）
      サンプル N 平均値 SD CV%
      Pos.Serum 14 4.7%

    • サンプルの種類

      Serum, Hep Plasma, Cit plasma

    • アッセイタイプ

      Indirect

    • ステップ

      Multiple steps standard assay

    • 種交差性

      交差種: Human

    • 製品の概要

      Abcam’s anti-Influenza virus B IgA Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate qualitative measurement of IgA class antibodies against Influenza virus B in Human serum and plasma.

      A 96-well plate has been precoated with Influenza virus B antigens to bind cognate antibodies. Controls or test samples are added to the wells and incubated. Following washing, a horseradish peroxidase (HRP) labelled anti-Human IgA conjugate is added to the wells, which binds to the immobilized Influenza virus B-specific antibodies. TMB is then catalyzed by the HRP to produce a blue color product that changes to yellow after adding an acidic stop solution. The density of yellow coloration is directly proportional to the amount of Influenza virus B IgA sample captured in plate.

    • 試験プラットフォーム

      Microplate

    製品の特性

    画像

    • Serologic ELISA assay principle
      Serologic ELISA assay principle
      Specific antigens are coated on the 96-well plate, controls or test samples are added to the well and incubated. The wells are washed to remove any unbound Human anti-antigen antibodies (Ig). A horseradish peroxidase (HRP) labelled anti-Human Ig conjugate is added to the wells. TMB is then catalyzed by the HRP to produce a blue color product that changes to yellow after adding an acidic stop solution. The intensity of yellow coloration is directly proportional to the amount of Human anti-antigen Ig captured on the plate.

    参考文献 (0)

    ab108744 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

    ab108744 は論文での使用が確認できていません。

    レビューと Q&A

    Show All レビュー Q&A
    レビューを送る 質問を送る

    1-2 of 2 Abreviews or Q&A

    Question

    Dear Abcam, Thanks for your reply. We intend to monitor anit-flu serum IgA from people who are vaccined with t rivalent flu vaccine, which virus strains a re A/California/7/2009 (H1N1), A/Victoria/210/2009 (H3N2) and B/Brisbane/60/2008. Here are our further inquiry. 1. Are ab108743 and ab108744 suitable for detecting our serum sample? Since the coated antigen seems not exactly the same as our vaccine strain. 2. Could we detect IgA from nasal swab sample with your ELISA kit? Do you have suggested sample preparation method for nsasal swab sample ? Thanks for your time. Best regard,

    Read More
    Answer

    Thank you for your patience. Unfortunately, these kits have not been tested with the virus strains you are using and also not with nasal swaps and we do not know if this would work. I also have an additional concern: I understand you want to detect IgA antibodies which are synthesized as response to a vaccination with Influenza antigens. We have no data or literature about that but is very unlikely that the body will create IgA antibodies. This kind of antibody is a response of the mucosa to contact with a pathogen. In case of a vaccination there is no mucosa contact and hence I believe the production of IgA antibodies is improbable unless the vaccination is being administered intra nasally. I am sorry that I could not provide you with a positive answer on this occasion and hope this information is nevertheless helpful.

    Read More

    Question

    Dear Abcam, We are intrested in your 2 products, Influenza Virus A IgA Human ELISA Kit (ab108743) and Influenza Virus B IgA Human ELISA Kit (ab108744). However, we have two issues for you. 1. Can you tell us which flu antigen is coated on the strip? Whole influenza virus, splitted flu antigen or influenza HA protein only or other any form of flu antigen? 2. Can you tell me what immunogen are postive control and cut-off control serum against to, ex. whole flu virus, flu HA only or other epitope? We are intended to analyse influenza split vaccine immunized human serum and we concern about the vaccine might just contain HA antigen. By the way, do you sell human anti-influenza HA IgA serum which can be used for standard control and quantitation standard curve? Thanks for your time. Best regards,

    Read More
    Answer

    Thank you for your inquiry. Ploease see the answer to your questions below: 1. For Influenza A IgA ELISA, ab108743, the wells are coated with purified Influenza A grade 2 antigens, strain Texas 1/77 (H3N2). For Influenza B IgA ELISA, ab108744, the wells are coated with purified Influenza B grade 2 antigens, strain Honk Kong 5/72. I can confirm that this ia a mixture of antigens and not only HA antigen. 2. I can confirm that the controls and cut-off control consists of positive human serum with preservative. Unfortunately, we do not sell human anti-influenza HA IgA serum at the moment. But I believe this is not necessary with this kit, since the control already consists of positive human serum. I hope this information is helpful and wish you good luck with your research.

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com